orbax oral suspension 3%
schering-plough limited - orbifloxacin 30 mg/ml - oral suspension - cats, dogs - orbifloxacin
orbax 25 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 25.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbax 6.25 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 6.25 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbax 75 mg tablets for dogs and cats
intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis
orbifloxacin
intervet australia pty limited - orbifloxacin - unknown - orbifloxacin antibiotic active 0.0 - active constituent
posatex
intervet international bv - orbifloxacin, mometasone furoate, posaconazole - otologicals - dogs - treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular malassezia pachydermatis.
posatex- orbifloxacin, mometasone furoate, and posaconazole suspension
merck sharp & dohme corp. - orbifloxacin (unii: 660932tpy6) (orbifloxacin - unii:660932tpy6), mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8), posaconazole (unii: 6tk1g07bhz) (posaconazole - unii:6tk1g07bhz) - indications: posatex® otic suspension is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast (malassezia pachydermatis) and bacteria (coagulase positive staphylococci, pseudomonas aeruginosa , and enterococcus faecalis ). contraindications : posatex® otic suspension is contraindicated in dogs with known or suspected hypersensitivity to quinolones, mometasone furoate monohydrate, or posaconazole. do not use in dogs with known tympanic perforation (see precautions ).
posatex veterinary
intervet ( israel) ltd - mometasone furoate (as monohydrate); orbifloxacin; posaconazole - ear drops suspension - orbifloxacin 8.5 mg/ml; mometasone furoate (as monohydrate) 0.9 mg/ml; posaconazole 0.9 mg/ml - dogs: treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular malassezia pachydermatis
posatex
schering-plough animal health limited - mometasone furoate monohydrate; posaconazole; orbifloxacin - mometasone furoate monohydrate 1 g/kg; posaconazole 1 g/kg; orbifloxacin 10 g/kg - antibiotic
orbax tablet
intervet canada corp - orbifloxacin - tablet - 5.7mg - orbifloxacin 5.7mg - cats; dogs